Epigenetic modulation of the MAPK pathway prevents isoflurane-induced neuronal apoptosis and cognitive decline in

Lei Huang1, Hai-Bin Fang1, Hui-Hui Cheng1

  • 1Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China.

Insights

Isoflurane anesthesia impairs cognition in aged rats by increasing histone deacetylases (HDACs) and neuronal apoptosis. Pre-treating with an HDAC inhibitor, MS-275, reversed these effects and improved cognitive function.

Area of Science:

  • Neuroscience
  • Anesthesiology
  • Epigenetics

Background:

  • Isoflurane anesthesia is widely used but linked to cognitive impairment.
  • The exact mechanisms behind isoflurane-induced cognitive decline, including neuro-inflammation and apoptosis, are not fully understood.
  • Histone deacetylases (HDACs) play a role in epigenetic regulation and have been implicated in neurological disorders.

Purpose of the Study:

  • To investigate the role of HDACs in isoflurane-induced cognitive decline in aged rats.
  • To examine the protective effects of the HDAC inhibitor MS-275 against isoflurane-induced neuronal damage and cognitive impairment.
  • To elucidate the impact of isoflurane and MS-275 on apoptosis and MAPK signaling pathways.

Main Methods:

  • Aged male Sprague-Dawley rats were divided into control, isoflurane (ISO), and MS-275 pre-treated groups.
  • Hippocampal tissues were analyzed using quantitative PCR, TUNEL staining, and Western blot.
  • Cognitive function was assessed using the Morris water maze test.

Main Results:

  • Isoflurane exposure significantly increased the expression of HDAC-1, -2, and -3.
  • MS-275 pre-treatment markedly reduced isoflurane-induced neuronal apoptosis (TUNEL-positive cells, caspase-3, Bax) and increased Bcl-2 expression.
  • MS-275 reversed isoflurane-induced alterations in MAPK pathway signaling (ERK1/2, JNK, p38) and improved performance in the Morris water maze.

Conclusions:

  • Isoflurane exposure promotes cognitive decline in aged rats through epigenetic modulation of neuronal apoptosis and MAPK signaling via HDAC upregulation.
  • Pre-treatment with the HDAC inhibitor MS-275 offers neuroprotection against isoflurane-induced cognitive impairment.
  • Targeting HDACs may represent a therapeutic strategy to mitigate the adverse cognitive effects of isoflurane anesthesia.

Related Concept Videos